CBSC announces $375,000 Noventis Medical purchase order and new recurring revenue program for MyCardia AT cardiac monitoring devices.

CBSC宣布37.5万美元采购订单及循环收入项目

CBSC secures $375K purchase order with Noventis Medical and launches recurring revenue program for MyCardia AT devices.

Cardiac Biotech Solutions signs exclusive $600K Noventis Medical distribution agreement for Latin America.

心脏生物科技解决方案(CBSC)签署覆盖中美洲和南美洲的独家五年分销协议

Cardiac Biotech Solutions, Inc. signs $600K exclusive distribution deal with Noventis Medical, expanding cardiac monitoring reach into Latin America.

CB科学公司宣布提交增强版myCam心脏事件监测仪FDA 510(k)申请

Updated product to include significant operating improvements and material design advances over the current offering

更新版myCam心脏事件监测设备进入监管测试阶段

Enhanced product to include significant operating enhancements and material design advances over the current offering

How can we help you?

Tell us what you are interested in.

订阅我们的新闻邮件!

订阅我们的电子报,我们将直接向您发送最新消息。